Helping patients find the leukemia resources they deserve
How do we help leukemia patients?
Massive Bio offers clinical trial matching services an individual cancer treatment analysis for leukemia patients. Our patient advocates work closely with patients to gather information on their current medical status, and then will provide a list of options from available cancer clinical trials close to your home.
Our team can also provide a comprehensive case analysis through our Virtual Tumor Board services from cancer specialists. The Virtual Tumor Board (VTB) is made up of highly specialized oncologists from nationally-recognized Cancer Centers of Excellence. In just 7-10 days after receiving your medical records, we can get you a treatment plan without having to travel far distances and use your valuable time.
Leukemia clinical trials work in researching to find more effective and safer treatments by studying new drugs or existing drugs but with different doses and methods of delivery, such as liposomal encapsulation. Over the last few years, research done by clinical trials has helped the overall survival of leukemia patients and has led to advances and understanding of the genetic make-up of leukemia and new ways to treat it.
Clinical trials are beneficial in that they you are first in line for treatments and procedures that have yet to be approved into standard care treatment, and it also contributes to overall leukemia research. By joining a clinical trial, you are not only helping yourself, but also future leukemia patients. If you are considering joining a clinical trial, consult with your oncologist.
With just a few clicks, you can see your clinical trial matches now. Click here to use our advanced clinical trial match tool.
According to the Leukemia and Lymphoma Society, an estimated 85,720 are expected to be diagnosed with leukemia in 2020 and every 3 minutes a person in the US is diagnosed with a blood cancer. Another 376,508 people in the US are currently living or are in remission for leukemia. Since the 1960 to 1963, the 5-year survival rate for leukemia has more than quadrupled from 14% among whites to 65.8%.
Leukemia is thought to happen when certain blood cells gain mutations in their DNA. These abnormalities then cause the cell to grow and divide at a faster rate than healthy cells, which outnumber the healthy cells in the bone marrow and lead to fewer heathy white blood cells, red blood cells and platelets.
Leukemia treatments are determined based on a patient’s age, overall health, type of leukemia and whether or not it has spread to other parts of the body.
Common treatments include:
- Biological therapy
- Targeted therapy
- Radiation therapy
- Small cell transplant
In order to diagnose leukemia, a doctor may perform a route blood test before any signs of symptoms. After any symptoms, they may also perform a physical exam to look for any physical signs of leukemia such as pale skin, swollen lymph nodes or enlargement of the liver and spleen. Additional blood test to analyze blood samples for abnormal levels of red or white blood cells or platelets may also be performed. Finally, a bone marrow test may also be recommended to look for any evidence of leukemia cells within the bone marrow.
Acute lymphocytic leukemia (ALL)
Acute myeloid leukemia (AML)
Chronic lymphocytic leukemia (CLL)
hronic myeloid leukemia (CML)
Hairy cell leukemia (HCL)
Myelodysplastic syndromes (MDS)
Our team of patient advocates can help guide you to treatment options you might not have been previously aware of. Although you might be new to cancer, we certainly are not. Navigating cancer patients through the tricky path of finding the best treatment is our goal. No two cancer patients are the same, which is why we find treatment for all of our patients based on their specific genomics, location, stage of cancer, and nearly 100 more data points.